Twist Bioscience Corporation (NASDAQ:TWST), a synthetic DNA specialist with a market capitalization of $2.8 billion, recently held its Annual Meeting of Stockholders, resulting in significant ...

In a challenging market environment, Lexaria Bioscience Corp. (NASDAQ:LEXX) stock has touched a 52-week low, dipping to $1.62. With a market capitalization of $28.7 million, InvestingPro analysis ...

SK bioscience completes WHO project as sole private participant for SARS standards SK bioscience achieves notable milestone ...

Chief Executive Tom Polen said he believes the separation would help differentiate BD in the medical-technology industry, and ...

Luna Bioscience moves ahead with work on a vaccine to prevent a deadly infection that spreads from animals to humans, as ...

One of Cincinnati’s best-funded startups further cemented its place on that list last year.

BlueArc Biosciences has been a winner in all three phases so far of the LymeX Innovation Accelerator competition as it works ...

LUND, SE / ACCESS Newswire / February 6, 2025 / Alligator Bioscience (STO:ATORX) FDA feedback validates the clinical ...

A sales process is underway after Manuka Bioscience's chair and major lender Wayne Wright called on loan agreements.

Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of ...